2023 Q2 Form 10-Q Financial Statement

#000155837023008767 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $74.61M $78.49M
YoY Change 5.53% 8.16%
Cost Of Revenue $45.85M $49.17M
YoY Change 10.82% 11.86%
Gross Profit $28.76M $29.32M
YoY Change -1.94% 2.48%
Gross Profit Margin 38.55% 37.35%
Selling, General & Admin $22.33M $20.67M
YoY Change 6.92% 5.53%
% of Gross Profit 77.64% 70.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.569M $1.597M
YoY Change 20.88% 23.89%
% of Gross Profit 5.46% 5.45%
Operating Expenses $23.90M $20.67M
YoY Change 14.43% 5.53%
Operating Profit $4.863M $7.050M
YoY Change -31.97% -8.82%
Interest Expense -$1.154M $1.736M
YoY Change -289.18% 208.35%
% of Operating Profit -23.73% 24.62%
Other Income/Expense, Net
YoY Change
Pretax Income $3.709M $5.200M
YoY Change -44.64% -27.78%
Income Tax $1.376M $1.713M
% Of Pretax Income 37.1% 32.94%
Net Earnings $2.333M $3.491M
YoY Change -52.94% -29.19%
Net Earnings / Revenue 3.13% 4.45%
Basic Earnings Per Share $0.05 $0.07
Diluted Earnings Per Share $0.05 $0.07
COMMON SHARES
Basic Shares Outstanding 48.38M 48.41M
Diluted Shares Outstanding 50.32M 50.29M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.57M $23.72M
YoY Change -37.83% -45.67%
Cash & Equivalents $19.57M $23.72M
Short-Term Investments
Other Short-Term Assets $5.968M $5.614M
YoY Change 63.06% 53.18%
Inventory
Prepaid Expenses
Receivables $87.38M $87.09M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.9M $116.4M
YoY Change 9.08% 1.7%
LONG-TERM ASSETS
Property, Plant & Equipment $11.12M $11.92M
YoY Change 84.9% 89.03%
Goodwill $94.95M $94.97M
YoY Change 4.81% 4.58%
Intangibles $12.80M $13.59M
YoY Change 12.74% 14.3%
Long-Term Investments
YoY Change
Other Assets $6.949M $3.737M
YoY Change 187.62% -6.13%
Total Long-Term Assets $125.8M $127.2M
YoY Change 6.84% 5.94%
TOTAL ASSETS
Total Short-Term Assets $112.9M $116.4M
Total Long-Term Assets $125.8M $127.2M
Total Assets $238.7M $243.7M
YoY Change 7.89% 3.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.928M $13.53M
YoY Change -25.44% 3.14%
Accrued Expenses $23.70M $23.28M
YoY Change -5.99% -26.92%
Deferred Revenue $6.902M $6.140M
YoY Change -6.74% -18.21%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $39.53M $42.95M
YoY Change -19.13% -24.36%
LONG-TERM LIABILITIES
Long-Term Debt $79.18M $79.18M
YoY Change 17.38% 15.63%
Other Long-Term Liabilities $14.00M $10.85M
YoY Change 169.34% 79.86%
Total Long-Term Liabilities $93.18M $90.03M
YoY Change 28.25% 20.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.53M $42.95M
Total Long-Term Liabilities $93.18M $90.03M
Total Liabilities $135.3M $139.9M
YoY Change 6.44% 1.98%
SHAREHOLDERS EQUITY
Retained Earnings -$103.0M -$105.4M
YoY Change -13.12% -14.71%
Common Stock $221.1M $225.4M
YoY Change -5.11% -4.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.5M $103.8M
YoY Change
Total Liabilities & Shareholders Equity $238.7M $243.7M
YoY Change 7.89% 3.87%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $2.333M $3.491M
YoY Change -52.94% -29.19%
Depreciation, Depletion And Amortization $1.569M $1.597M
YoY Change 20.88% 23.89%
Cash From Operating Activities $2.821M -$3.374M
YoY Change 241.94% -182.07%
INVESTING ACTIVITIES
Capital Expenditures $468.0K $501.0K
YoY Change -144.23% -52.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$468.0K -$501.0K
YoY Change -55.77% -52.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.348M -3.176M
YoY Change -34.36% -50.28%
NET CHANGE
Cash From Operating Activities 2.821M -3.374M
Cash From Investing Activities -468.0K -501.0K
Cash From Financing Activities -6.348M -3.176M
Net Change In Cash -3.995M -6.864M
YoY Change -59.66% 77.87%
FREE CASH FLOW
Cash From Operating Activities $2.821M -$3.374M
Capital Expenditures $468.0K $501.0K
Free Cash Flow $2.353M -$3.875M
YoY Change 24.96% -226.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001371489
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Debt Instrument Valuation Technique Extensible List
DebtInstrumentValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueDiscountedCashFlowMember
CY2022Q4 us-gaap Debt Instrument Valuation Technique Extensible List
DebtInstrumentValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueDiscountedCashFlowMember
CY2023Q1 us-gaap Debt Instrument Measurement Input Extensible List
DebtInstrumentMeasurementInputExtensibleList
http://fasb.org/us-gaap/2022#MeasurementInputDiscountRateMember
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
298000
CY2022Q4 us-gaap Debt Instrument Measurement Input Extensible List
DebtInstrumentMeasurementInputExtensibleList
http://fasb.org/us-gaap/2022#MeasurementInputDiscountRateMember
CY2022Q4 us-gaap Goodwill
Goodwill
94972000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13585000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14380000
CY2023Q1 us-gaap Debt Instrument Valuation Technique Extensible List
DebtInstrumentValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueDiscountedCashFlowMember
CY2022Q4 us-gaap Debt Instrument Valuation Technique Extensible List
DebtInstrumentValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueDiscountedCashFlowMember
CY2023Q1 us-gaap Debt Instrument Measurement Input Extensible List
DebtInstrumentMeasurementInputExtensibleList
http://fasb.org/us-gaap/2022#MeasurementInputDiscountRateMember
CY2022Q4 us-gaap Debt Instrument Measurement Input Extensible List
DebtInstrumentMeasurementInputExtensibleList
http://fasb.org/us-gaap/2022#MeasurementInputDiscountRateMember
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Information Services Group Inc.
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33287
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5261587
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2187 Atlantic Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stamford
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06902
CY2023Q1 dei City Area Code
CityAreaCode
203
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
517-3100
CY2023Q1 dei Security12b Title
Security12bTitle
Shares of Common Stock, $0.001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
III
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48382738
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23722000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30587000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
636000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
272000
CY2023Q1 iii Accounts Receivable And Contract Assets Net
AccountsReceivableAndContractAssetsNet
87087000
CY2022Q4 iii Accounts Receivable And Contract Assets Net
AccountsReceivableAndContractAssetsNet
80170000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5614000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4724000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
116423000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
115481000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
84000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
83000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5561000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5929000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6363000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6780000
CY2023Q1 us-gaap Goodwill
Goodwill
94970000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2930000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2818000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3737000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2585000
CY2023Q1 us-gaap Assets
Assets
243653000
CY2022Q4 us-gaap Assets
Assets
243028000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13533000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15925000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4300000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6140000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7058000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
23278000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
23908000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
42951000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51191000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
79175000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
74416000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2433000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2391000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4457000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4857000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10853000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9742000
CY2023Q1 us-gaap Liabilities
Liabilities
139869000
CY2022Q4 us-gaap Liabilities
Liabilities
142597000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49472000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48378000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49472000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48300000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
49000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
225333000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
226293000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1094000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1172000
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
6878000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
7487000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9354000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9677000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105366000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108747000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
103784000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
100431000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243653000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243028000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78486000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72563000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5156000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49169000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43955000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20670000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19587000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1597000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1289000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7050000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7732000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
84000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
45000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1736000
CY2022Q1 us-gaap Interest Expense
InterestExpense
563000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-194000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
24000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5204000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7238000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1713000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2308000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3491000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4930000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48438000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48526000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50288000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51326000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3491000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4930000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
97000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-169000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
323000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-534000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3814000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4396000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
100431000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3491000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
323000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
698000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
208000
CY2023Q1 iii Adjustments To Additional Paid In Capital Accrued Dividends On Unvested Shares
AdjustmentsToAdditionalPaidInCapitalAccruedDividendsOnUnvestedShares
-57000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.04
CY2023Q1 iii Dividends Common Stock Cash Paid
DividendsCommonStockCashPaid
1960000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2042000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
103784000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
98393000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4930000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-534000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5489000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
186000
CY2022Q1 iii Adjustments To Additional Paid In Capital Accrued Dividends On Unvested Shares
AdjustmentsToAdditionalPaidInCapitalAccruedDividendsOnUnvestedShares
101000
CY2022Q1 iii Dividends Common Stock Payable
DividendsCommonStockPayable
1447000
CY2022Q1 iii Dividends Common Stock Cash Paid
DividendsCommonStockCashPaid
10000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1503000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
97431000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3491000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4930000
CY2023Q1 us-gaap Depreciation
Depreciation
803000
CY2022Q1 us-gaap Depreciation
Depreciation
761000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
794000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
528000
CY2023Q1 iii Deferred Tax Benefit Expense From Stock Issuances
DeferredTaxBenefitExpenseFromStockIssuances
35000
CY2022Q1 iii Deferred Tax Benefit Expense From Stock Issuances
DeferredTaxBenefitExpenseFromStockIssuances
-129000
CY2023Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
379000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
86000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2042000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1503000
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
25000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1428000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
217000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
300000
CY2023Q1 iii Deferred Income Tax Expense Benefit Adjustments
DeferredIncomeTaxExpenseBenefitAdjustments
-211000
CY2022Q1 iii Deferred Income Tax Expense Benefit Adjustments
DeferredIncomeTaxExpenseBenefitAdjustments
256000
CY2023Q1 iii Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
6776000
CY2022Q1 iii Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
2996000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
708000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1499000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2632000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3390000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-919000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
457000
CY2023Q1 iii Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
15000
CY2022Q1 iii Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
-1122000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3374000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4111000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
501000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1046000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-501000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1046000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
79175000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
79175000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1075000
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
208000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
186000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
827000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
299000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
333000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1960000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3176000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6388000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
187000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-536000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6864000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3859000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30670000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47609000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23806000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43750000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1119000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
413000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1750000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1088000
CY2023Q1 iii Issuance Of Treasury Stock For Espp And Vested Restricted Stock Awards And Stock Appreciation Rights
IssuanceOfTreasuryStockForESPPAndVestedRestrictedStockAwardsAndStockAppreciationRights
1009000
CY2022Q1 iii Issuance Of Treasury Stock For Espp And Vested Restricted Stock Awards And Stock Appreciation Rights
IssuanceOfTreasuryStockForESPPAndVestedRestrictedStockAwardsAndStockAppreciationRights
840000
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">NOTE 1—DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Information Services Group, Inc. (Nasdaq: III) (the “Company,” “ISG,” “we,” “us” or “our”) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the top 100 enterprises in our markets, ISG is committed to helping corporations, public sector organizations and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; technology strategy and operations design; change management; market intelligence and technology research and analysis. Based in Stamford, Connecticut, ISG employs approximately 1,600 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com. The information on or accessible through our website is not part of and is not incorporated by reference into this Quarterly Report on Form 10-Q, and the inclusion of our website address in this Quarterly Report on Form 10-Q is only for reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Our Company was founded in 2006 with the strategic vision to become a high-growth, leading provider of information-based advisory services. We continue to believe that our vision will be realized through the acquisition, integration and successful operation of market leading brands within the data, analytics and advisory industry.</p>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. Actual results may differ from those estimates. The complexity of the estimation process and issues related to the assumptions, risks and uncertainties inherent in the application of the revenue recognition guidance for contracts in which control is transferred to the customer over time affect the amounts of revenues, expenses, contract assets and contract liabilities. Numerous internal and external factors can affect estimates. Estimates are also used for but not limited to: allowance for credit losses, useful lives of furniture, fixtures and equipment and definite lived intangible assets, depreciation expense, fair value </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">assumptions in evaluating goodwill for impairment, income taxes and deferred tax asset valuation and the valuation of stock-based compensation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.319
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5200000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5593000
CY2023Q1 iii Business Combination Contingent Consideration Liability Accretion
BusinessCombinationContingentConsiderationLiabilityAccretion
25000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5618000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
79200000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
79200000
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
79800000
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
76500000
CY2023Q1 us-gaap Debt Instrument Measurement Input
DebtInstrumentMeasurementInput
0.065
CY2022Q4 us-gaap Debt Instrument Measurement Input
DebtInstrumentMeasurementInput
0.063
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.329
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
40177000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
32249000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6140000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7058000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3500000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
132600000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3491000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4930000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48438000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48526000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3491000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4930000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48438000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48526000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1850000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2800000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50288000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51326000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7200000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78486000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72563000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
79200000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
79200000
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
79800000
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
76500000
CY2023Q1 us-gaap Debt Instrument Measurement Input
DebtInstrumentMeasurementInput
0.065
CY2022Q4 us-gaap Debt Instrument Measurement Input
DebtInstrumentMeasurementInput
0.063

Files In Submission

Name View Source Status
iii-20230331_def.xml Edgar Link unprocessable
iii-20230331_pre.xml Edgar Link unprocessable
iii-20230331_lab.xml Edgar Link unprocessable
0001558370-23-008767-index-headers.html Edgar Link pending
0001558370-23-008767-index.html Edgar Link pending
0001558370-23-008767.txt Edgar Link pending
0001558370-23-008767-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iii-20230331.xsd Edgar Link pending
iii-20230331x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
iii-20230331xex31d1.htm Edgar Link pending
iii-20230331xex31d2.htm Edgar Link pending
iii-20230331xex32d1.htm Edgar Link pending
iii-20230331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
iii-20230331_cal.xml Edgar Link unprocessable
iii-20230331x10q_htm.xml Edgar Link completed